Biotin is an archetypal vitamin used as cofactor for carboxylation reactions found in all forms of 28 life. However, biotin biosynthesis is an elaborate multi-enzymatic process and metabolically 29 costly. Moreover, many industrially relevant organisms are incapable of biotin synthesis 30 resulting in the requirement to supplement defined media. Here we describe the creation of 31 biotin-independent strains of Escherichia coli and Corynebacterium glutamicum through 32 installation of an optimized malonyl-CoA bypass, which re-routes natural fatty acid synthesis, 33 rendering the previously essential vitamin completely obsolete. We utilize biotin-independent 34 E. coli for the production of the high-value protein streptavidin which was hitherto restricted 35 because of toxic effects due to biotin depletion. The engineered strain revealed significantly 36 improved streptavidin production resulting in the highest titers and productivities reported for 37 this protein to date. 38 39 40
Introduction

52
Vitamins play an important role as cofactors in enzymes and fulfill a multitude of other essential 53 biological functions including signaling, regulation, electron transfer, oxidation protection and 54 radical scavenging 1 . Correspondingly, vitamin deprivation or inadequate intake cause severe 55 metabolic disorders such as cardiovascular disease, increased risk for cancer and miscarriage, 56 and osteoporosis to name but a few 2 . Biotin (or vitamin B7/H) constitutes an archetypal 57 representative for vitamins since it is inevitably required by most independently living organisms 58 distributed over the three domains of life 1 with some exceptions in archaeal clades 3 . While only 59 synthesized by some bacteria, yeasts, molds, algae and plants, mammals rely on dietary uptake of 60 the vitamin or its supply from the intestinal microflora 1,4 . Biotin serves as enzymatic cofactor in 61 carboxylation reactions in fatty acid biosynthesis, amino acid metabolism and gluconeogenesis 62 where it activates CO 2 for the carboxyltransfer domains of the respective enzymes 4,5 . 63 Several industrially relevant microorganisms lack the ability to independently synthesize biotin 64 including Saccharomyces cerevisiae 6 , Pichia pastoris 7 and Corynebacterium glutamicum 8, 9 . In 65 the case of P. pastoris, for instance, high amounts of the cofactor are added to defined media and 66 process complications are frequently associated with poor quality of the supplemented biotin 7 . 67 Similarly, biotin has to be added in serum-free cell culture medium formulations 10 . In order to 68 overcome this limitation, several efforts have been undertaken to genetically engineer 69 prototrophic variants of different organisms for industrial applications 6-9 . These works comprised 70 introduction of biotin biosynthesis genes from naturally prototrophic hosts like Escherichia coli 71 or Bacillus subtilis. An alternative approach to the aforementioned efforts could be the metabolic 72 engineering of biotin-independent organisms that a priori do no longer rely on biotin, which has 73 thus far not been systematically elaborated. 74 Biotin metabolism has been extensively studied in E. coli 4, 5, 11, 12 , where it is used for the 75 carboxylation of acetyl-CoA to yield malonyl-CoA which represents the first committed step in 76 fatty acid synthesis 13 (Fig. 1 ). This reaction catalyzed by the acetyl-CoA carboxylase complex 77 (AccABCD) is the only essential utilization of biotin in E. coli. Other than that, only propionate 78 metabolism has been reported to rely on biotin for the carboxylation of propionyl-CoA in some 79 strains but the corresponding genes and gene products remain elusive 14 . Despite its scarce usage, 80 the biosynthesis of biotin is a metabolically costly procedure involving many enzymatic steps 81 ( Fig. 1) : starting from glucose, a minimum of twelve enzymatic reaction steps is required to yield 82 acetyl-CoA 15 , which is then converted into malonyl-CoA by the aforementioned AccABCD 83 reaction 13 . Subsequently, the fatty acid synthesis machinery is employed to successively couple 84 three malonyl-CoA units in ten enzymatic steps to yield pimeloyl-ACP methyl ester 4 . This 85 precursor is processed into biotin by five final biosynthesis enzymes (BioHFADB) before 86 loading the cofactor onto the biotinyl carboxyl carrier protein (BCCP) by the biotin ligase BirA 4 . 87 Hence, at least 29 steps are required to produce biotin including the comparably inefficient, yet 88 catalytic, final biotin synthase (BioB) reaction 16,17 and not to mention involved cofactors (SAM, 89 NAD(P) + /NAD(P)H, CoA, ATP etc.) and the genetics of biotin biosynthesis including 90 regulation 18, 19 . 91 In this work we describe the creation of biotin-independent phenotypes by re-wiring initial fatty 92 acid biosynthesis using a malonyl-CoA bypass. The resulting engineered strains of E. coli and 93 C. glutamicum are able to survive and proliferate in the complete absence of biotin. We apply 94 this concept of biotin-independence to improve the production of the high-affinity biotin binder 95 streptavidin (SAV hereafter), which was thus far restricted due to toxic biotin depletion in the 96 host cell. The biotin-independent E. coli strain revealed a significantly enhanced SAV production 97 as well as improved growth behavior as compared to a conventional strain. Transferring this 98 strategy to an SAV production process in lab-scale bioreactors and fine-tuning of the bypass led 99 to the highest streptavidin titers reported to date (up to 8.3±0.2 g L -1 ). exclusive to biotin production (green box). AccABCD requires biotin as cofactor for the essential conversion of 106 acetyl-CoA to malonyl-CoA during fatty acid synthesis in most natural organisms 20 . Bypassing this reaction creates 107 a biotin-independent phenotype achieved by implementing two heterologous proteins from R. trifolii (blue box) 108 facilitating uptake of malonate (MatC) and its subsequent conversion to malonyl-CoA (MatB). The resulting strain 109 should be superior to conventional hosts in its capability to produce biotin-binders such as streptavidin (SAV; red 110 box), which is hitherto restricted due to the sequestration of biotin and inhibition of AccABCD where appropriate. The basic M9 medium 23 contained 10 g L -1 glucose and 20 mg L -1 thiamine. 128 For the experiments with JM83 and its derivatives ( adjusting the stirrer speed (300 to 1250 rpm, 50 rpm increments; two six-blade Rushton 171 impellers) and secondly the air flow (1 to 5 vvm). 172 The batch phase was started by inoculation of 2 L of defined mineral medium to an initial OD 600 173 of 0.15 from an overnight shake flask pre-culture in the same medium. In order to prevent 174 foaming 1 mL of 20% (v/v) of polypropylene glycol was added to the culture and additionally as 175 necessary in 500 µL increments throughout the cultivation. After the consumption of the initial 176 amount of glucose (10 g L -1 ), as indicated by a sudden rise in the dissolved oxygen signal, 177 glucose feed medium was gradually applied to the culture in an exponential manner (µ set = 178 0.09 h -1 ) until an approximate OD 600 of 55 was reached (corresponding to a dry cell weight 179 concentration (DCW) of roughly 21 g L -1 ). Subsequently, heterologous gene expression was 180 induced by addition of 500 µM IPTG and the administered medium was switched to glucose-181 malonate feed medium which was applied at a constant rate of 0.53 mL min -1 until the end of the 182 process. Cell growth was monitored throughout the process by OD 600 Supplementary Fig. 4 ). Therefore cell lysates from one of 237 the biotin-independent bioreactor processes ( Fig. 4(c) ) were run in comparison to a purified, 238 lyophilized SAV standard corresponding to a concentration of 4 g L -1 . 273 We constructed three different matBC expression vectors for E. coli differing in the anticipated 274 expression levels by using different copy numbers and promoters and varying the start codon 275 (wild type GTG vs. ATG) of matB (Fig. 2(a) ). To test whether the only biotin-dependent reaction 276 can be bypassed by MatBC, we constructed a strain with disrupted chromosomal biotin synthase 277 gene bioB which reportedly prevents biotin production and thus growth in biotin-free medium 38 . 278 The resulting strain JM83(DE3)ΔbioB was transformed with the different matBC expression 279 plasmids and plated on selective M9-agar containing either 0.2 mg L -1 biotin or 5 mM malonate 280 as well as neither of the two supplements ( Fig. 2(b) ). Whereas parent strain JM83(DE3) 281 exhibited normal growth even in biotin absence, the bioB mutants failed to proliferate on biotin-282 free agar. As expected, supplementation of biotin to the medium restored growth for all 283 auxotroph mutants. Importantly, malonate was likewise able to restore growth but only in 284 presence of a matBC expression vector and with notably diverging strain fitness depending on 305 To quantify growth of the biotin-independent strain and investigate a potential influence of the 306 amount of supplemented malonate, we conducted cultivations of JM83(DE3)ΔbioB pCKmatBC 307 in microtiter plates (Fig. 2(c) ) and shake flasks (see Supplementary Fig. 1 ) in biotin-free M9 308 liquid medium. We found growth to depend on the supplied malonate concentration and 309 identified an optimum at which the growth rate was restored roughly to the same level as in 310 presence of biotin which corresponds well with typically observed growth rates for wildtype carboxylase is inessential and the corresponding deficient mutants exhibit wild type growth 45 . 331 We therefore hypothesized that the MatBC-bypass would likewise render biotin obsolete in 332 C. glutamicum creating mutants proficient to grow in biotin-free medium supplemented with 333 malonate. We constructed the vector pEKEx2matBC with the natural matBC cassette under 334 control of a P tac promoter. Gratifyingly, transformation of C. glutamicum wild type (ATCC 335 13032) with this construct enabled its proliferation in biotin-free media containing malonate 336 whereas in the absence of MatBC (pEKEx2) as well as in medium lacking malonate only 337 marginal growth due to residual biotin transferred from the pre-cultures was observable 338 (Fig. 2(d) ). Moreover, we found a strong growth inhibition for high inducer concentrations 339 pointing to a similar preference for low matBC expression levels as previously observed for 340 E. coli (see Supplementary Fig. 2) . Taken together these experiments highlight the feasibility to 341 create biotin-independent organisms using the MatBC bypass and the transferability of the 342 underlying concept to different hosts. been reported to lead to depletion of the host cell's biotin pool accompanied by impaired growth 356 and low SAV expression levels 21,22,50 , which represents a major limitation for high-yield SAV 357 production. 358 We presumed that the capability to bypass the critical biotin-sensitive metabolic step should lead 359 to superior behavior in SAV expression without the accompanying negative effects and should 360 therefore be of use for a corresponding SAV production strategy. We therefore introduced a 361 second plasmid (pET30T7SAV) with the SAV gene under the control of a P T7 promoter into a 362 strain harboring pCKmatBC ( Fig. 3(a) ). As production host we selected the strain E. coli 363 BL21(DE3) since it is conventionally used for high biomass production and protein expression. 364 Since BL21(DE3) is a biotin prototrophic strain, in the absence of SAV (before induction) the 365 malonyl-CoA bypass is not needed, but its expression from pCKmatBC can be concomitantly 366 activated with SAV induction from pET30T7SAV by addition of IPTG. This "switchable" 367 MatBC bypass allows for normal growth in the off-state without the need to supplement 368 malonate before induction, which is an important practical advantage. At the same time it should 369 facilitate improved growth and production behavior in the on-state after induction of SAV. 370 To validate this hypothesis we conducted SAV expression studies in shake flasks in M9 medium, 371 both with and without 5 mM malonate supplementation and in the absence (matBC -, empty 372 vector control) or presence of pCKmatBC (matBC + , Fig. 3(b) ). As expected, all four specimens 373 showed very similar growth in the off-state until addition of IPTG (dashed line). Afterwards, the 374 conditionally biotin-independent strain showed a significantly improved growth behavior only in 375 presence of malonate (matBC + MAL + ) as compared to the conventional strain (matBC -, MAL +/-) 376 and the control lacking malonate (matBC + MAL -). More importantly, SAV expression was 377 notably improved in the biotin-independent strain as reflected by a roughly two-fold increased 378 final concentration. We performed similar experiments with strain JM83(DE3) revealing similar 379 trends and a more than three-fold increase in SAV production (see Supplementary Fig. 3 ). These 380 results unambiguously demonstrate the functionality of the biotin-independent bypass and its 381 utility for improved expression of SAV. 3.5 Establishment of a biotin-independent streptavidin production process 393 Next, we transferred the switchable biotin-independent SAV production into a laboratory scale 394 bioreactor process using defined medium. Therefore we developed a cultivation protocol 395 composed of three conceptual stages ( Fig. 4(a) ): an initial batch phase (I), a fed-batch stage (II) 396 with exponential glucose-limited feeding (biomass production), and an SAV production stage 397 (III) initiated by induction with IPTG, during which a mixture of malonate and glucose is applied 398 in a constant manner throughout the rest of the process. Since the initial studies had pointed to a 399 critical requirement of a fine-tuned malonate supply depending on the cultivation conditions, we 400 investigated the effect of different malonate-to-glucose ratios in the feed medium during SAV 401 production (III) ( Fig. 4(b) ). The strain lacking matBC reproducibly yielded similar amounts of 402 SAV (~4 g L -1 ) regardless of the malonate amount fed to the broth. In stark contrast the biotin-403 independent strain (matBC + ) showed a production behavior depending on the applied malonate 404 amount with a peak concentration of 7.3±0.2 g L -1 SAV at 0.56 mmol malonate per gram of 405 glucose. To demonstrate reproducibility we performed replicate bioreactor runs at the identified 406 malonate optimum (Fig. 4(c) ). The biotin-independent strain outperformed the conventional 407 strain both with respect to growth and SAV production and allowed for a reproducibly higher 408 maximum product concentration of 7.5±0.7 g L -1 of active SAV (compared to 4.7±0.2 g L -1 ). The 409 best run yielded 8.3±0.2 g L -1 (or 126.3±3.0 µM tetramer) of product (compare also 410 Supplementary Fig. 4 ). This improvement can be attributed both to an improved growth after 411 induction of SAV expression as well as to an increased cell specific product yield of 412 approximately 49±4% of whole cell protein (as compared to 38±1% for the control) indicating 413 that the re-programmed strain's performance was driven close to the reported feasible maximum 414 for recombinant protein expression in E. coli 51 . 415 To the best of our knowledge the titers produced with the biotin-independent strain represent the 416 highest SAV concentrations reported to date and constitute a significant increase compared to 417 former benchmark studies 52,53 . Moreover, due to the high specific growth rate of E. coli, which 418 allows comparably short overall process times, the volumetric productivity was substantially 419 increased in comparison to previously used hosts for SAV production such as S. avidinii, P. productivity of the optimal setup (0.56 mmol g Glc -1 ) was verified by three independent bioreactor cultivations of the 429 biotin-independent strain (blue squares/circles) compared to two independent reference cultivations with the 430 conventional strain (matBC -) without malonate (grey squares/circles). Bars/data points represent averages of 431 triplicate measurements of dry cell weight (DCW) and SAV concentration with standard error. The area between the 432 dashed lines represents the IPTG induction window of all five processes. SDS-PAGE analysis for the biotin-433 independent process was performed to confirm integrity of the product (see Supplementary Fig. 4 ) 434 435
Optimization of malonate supply
Conclusion
436
Metabolic engineering is widely used to improve bioprocess performance by directing fluxes into 437 a desired product based on the ever increasing knowledge about cellular metabolic networks 55 . 438 Well established strategies include overexpression or deletion of inherent host enzymes to 439 increase the flux into the target pathway or prevent drainage of intermediates and consequently 440 product loss or side product formation, the integration of enzymes facilitating growth and 441 product formation based on inexpensive substrates, as well as implementation of proteins which 442 simplify downstream processing. These efforts are frequently combined with flux models that 443 help identifying the key bottlenecks within the system 56,57 .
444
A relatively uncharted approach is the fundamental re-organization of central host metabolism in 445 order to enhance bio-production. This strategy seeks to completely re-route central metabolic 446 pathways in order to drive their flux into a desired direction and is based on the notion that 447 natural metabolism, as good as it is to cope with natural challenges, may not be the preferable 448 choice for biotechnological application. Auspicious examples comprise a synthetic non-oxidative 449 glycolysis 58 and a reverse glyoxylate shunt 59 , both designed to minimize carbon loss upon 450 utilization of carbohydrates, as well as the engineering of artificial carbon fixation cycles with 451 the goal to increase sequestration of the greenhouse gas carbon dioxide 60-63 . Despite the fact that 452 some of these efforts thus far mainly comprised theoretical considerations and in vitro studies 453 and have therefore hardly exceeded the stage of a blueprint, this type of approach could arguably 454 enable to fundamentally change cellular metabolism as we know it today and may allow 455 accessibility to entirely novel processes and bio-products. 456 In this work we re-route the central pathway of fatty acid biosynthesis by installation of a bypass 457 for malonyl-CoA to liberate the corresponding strains of E. coli and C. glutamicum from their 458 dependence on biotin, an essential vitamin evolutionary conserved in all kingdoms of life. The 459 engineered organisms exhibit normal growth in the absence of the cofactor and can be used for 460 biotechnological applications as demonstrated on the test bed of SAV production, which was 461 previously restricted due to toxic biotin depletion in the host cell 21, 22, 50 . This led to the 462 establishment of an SAV production process with hitherto unmatched maximum titers and 463 productivities. 464 To extend the biotin-independent concept beyond this proof-of-principle study, the entire cellular 465 machinery associated with biotin could be removed from the host genome. This includes genes 466 involved in its biosynthesis (bioHFADB), its loading (birA), as well as all acetyl-CoA 467 carboxylase genes (accABCD). Furthermore, the presented MatBC bypass could be combined 468 with a module for in vivo synthesis of malonate, which has recently been established in an 469 engineered E. coli strain that is capable of synthesizing malonate from aspartate via a beta-470 alanine route 37 . This would close the gap to prevalent metabolites that can be directly derived 471 from central metabolism and render the currently required (yet inexpensive) supplementation of 472 malonate obsolete, leading to a stand-alone biotin-independent organism, which synthesizes fatty 473 acid building-blocks in a completely novel way. 474 We believe that this work represents a prime example indicating that even fundamental design 475 principles of cellular carbon flux in living cells can be simplified for synthetic purposes. This 476 suggests a hitherto largely unappreciated malleability of core metabolism, which augurs well for 477 future fundamental re-design of bacterial metabolism using abiotic reactions 48,64 . 
